Table 3 Fraction of people with diabetes using selected groups of medicines.
Total | Retinopathy grading | p Value* | ||||||
---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4a | 4b | |||
Type 1 diabetes | ||||||||
n | 656 | 311 | 137 | 161 | 19 | 5 | 32 | |
BP‐reducing drugs | 26.2 | 13.2 | 30.1 | 37.9 | 26.3 | 80.0 | 65.6 | 0 |
Oral antidiabetics | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Insulin | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | |
Lipid‐lowering drugs | 6.7 | 3.6 | 11.0 | 8.1 | 0 | 0 | 15.6 | 0.192 |
Type 2 diabetes | ||||||||
n | 328 | 193 | 40 | 71 | 12 | 1 | 2 | |
BP‐reducing drugs | 57.6 | 48.3 | 61.0 | 73.2 | 83.3 | 100.0 | 50.0 | 0 |
Oral antidiabetics | 36.3 | 40.8 | 29.3 | 29.6 | 33.3 | 0 | 0 | 0.064 |
Insulin | 64.9 | 53.7 | 80.5 | 83.1 | 83.3 | 100.0 | 100.0 | 0 |
Lipid‐lowering drugs | 27.1 | 27.4 | 22.0 | 32.4 | 16.7 | 0 | 0 | 0.988 |
BP, blood pressure.
p Values indicate possible trends across increasing levels.
*Trend across increasing grading (excluding 4b) was tested by Mantel–Haenszel linear‐by‐linear association.